OTC review agenda
This article was originally published in The Rose Sheet
Executive Summary
Target date for completing notice of proposed rulemaking for sunscreen UVA/UVB products pushed back to August in FDA's 1unified agenda published in the Federal Register Dec. 9. Most recent public estimate for completion was April (2"The Rose Sheet" May 20, 2002, In Brief). Proposal for providing labeling flexibility for "convenience" size OTC drugs targeted for March, while antiperspirant products final monograph is expected to be completed in April, agency adds. Final action on skin protectant products anticipated in April with NPRM for astringent scheduled to follow in August...